Photo of Shilpa Gupta taken from X/Twitter
Dec 23, 2023, 03:55
Shilpa Gupta: Our work on plat-ineligibility in Metastatic Urothelial Carcinoma and survival outcomes out in the Journal of the JNCI
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter:
“Our work on plat-ineligibility in Metastatic Urothelial Carcinoma (mUC) and survival outcomes out in the Journal of the National Cancer Institute (JNCI).
- First, to provide quantitative benchmarks
- Only 11% of >4000 patients plat-ineligible
- Poor median overall survival ~5 months
We used our previously defined criteria for plat-ineligibility. Unmet need to develop novel trials in plat-ineligible mUC patients. Ongoing trial of Anti-LAG/TIGIT/PD-L1 will help provide further insights. Enrolling globally. Available here.”
Source: Shilpa Gupta/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19